Institute of Molecular and Cell Biology And MerLion Pharmaceuticals Pte Ltd Collaborate On Drug Discovery And Development
10/19/2005 5:09:25 PM
MerLion Pharmaceuticals Pte Ltd (MerLion) and the Institute of Molecular and Cell Biology (IMCB) today announced a three-year drug discovery and development collaboration.
Under the collaboration, IMCB will provide MerLion with a series of selected drug targets and projects. MerLion will provide access to its extensive natural products sample collection and apply its screening and natural products chemistry skills to the isolation of new chemical leads and drug candidates. It will also supply its medicinal chemistry expertise in the optimisation and pre-clinical development of active chemical templates. MerLion and IMCB will work in partnership throughout the lead discovery and optimisation stages of the collaboration and share ownership of the output.
comments powered by